Global Information
회사소개 | 문의 | 비교리스트

세계의 호르몬 대체요법 시장 예측(2021-2028년)

Global Hormone Replacement Therapy Market Forecast 2021-2028

리서치사 Inkwood Research
발행일 2021년 05월 상품코드 1006536
페이지 정보 영문 217 Pages 배송안내 2-3일 (영업일 기준)
가격
US $ 2,500 ₩ 3,614,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 되지 않으며, 인쇄 또한 불가능합니다.
US $ 3,000 ₩ 4,337,000 PDF (Multi User License) help
동일 사업장(소재지) 내 5명까지 이용가능한 라이센스입니다. 인쇄는 1명당 1회에 한해 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 6,506,000 PDF (Enterprisewide License) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 호르몬 대체요법 시장 예측(2021-2028년) Global Hormone Replacement Therapy Market Forecast 2021-2028
발행일 : 2021년 05월 페이지 정보 : 영문 217 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 호르몬 대체요법(HRT) 시장 규모는 예측기간 중(2021-2028년)에 7.67%의 CAGR로 성장할 것으로 예측됩니다. 시장의 주요 성장 촉진요인으로 주요 기업으로부터의 제품 발매와 성장호르몬결핍증에 대한 사회적 인식 상승 등을 들 수 있습니다.

세계의 호르몬 대체요법(Hormone Replacement Therapy) 시장에 대해 분석했으며, 시장의 기본 구조와 주요 성장 촉진·억제요인, 시장 규모 동향 전망(과거 3년간·향후 9년간), 치료 종류별·적응증별·투여 경로별 및 지역별 상세 동향, 시장 경쟁 동향, 주요 기업 개요(기업 개요, 주요 제품/서비스, 사업 전략 등) 등에 대해 조사했습니다.

목차

제1장 분석 범위와 방법

제2장 주요 요약

제3장 시장 역학

  • 주요 시장 성장 촉진요인
    • 여성 사이에서의 폐경후 문제에 대한 일반적인 인식
    • 호르몬장애 발생률 상승
    • 주요 기업으로부터의 제품 발매
  • 주요 시장 성장 억제요인
    • 호르몬 대체요법과 관련된 유해 반응
    • 높은 치료비

제4장 주요 분석

  • COVID-19가 호르몬 대체요법 시장에 미치는 영향
  • 시장 동향
  • Porter's Five Forces 분석
  • 시장 기회 매트릭스
  • 벤더 상황

제5장 치료 종류별 시장

  • 에스트로겐 대체요법
  • 갑상선호르몬 대체요법
  • 테스토스테론 대체요법
  • 인간성장호르몬 대체요법
  • 프로게스토겐 대체요법

제6장 적응증별 시장

  • 폐경
  • 남성성선기능저하증
  • 성장호르몬결핍증
  • 갑상선기능저하증
  • 기타 적응증

제7장 투여 경로별 시장

  • 경구 투여
  • 비경구 투여
  • 경피흡수
  • 기타 투여 경로(RoA)

제8장 지역별 분석

  • 북미
    • 시장 규모 : 추정치
    • 주요 성장 실현요인
    • 주요 과제
    • 주요 기업
    • 국가별 분석
  • 유럽
  • 아시아태평양
  • 기타 국가(RoW)

제9장 경쟁 상황

  • 주요 전략 전개 상황
    • 기업 인수합병(M&A)
    • 제품 발매·개발
    • 사업 제휴·계약
    • 사업 확대/발표/기업 매각
  • 기업 개요
    • ABBOTT LABORATORIES
    • AMGEN
    • ANI PHARMACEUTICALS
    • BAYER AG
    • ELI LILLY & COMPANY
    • GENENTECH INC
    • IPSEN
    • MERCK KGAA
    • NOVARTIS AG
    • NOVEN PHARMACEUTICALS INC
    • NOVO NORDISK A/S
    • PFIZER INC
    • VIATRIS INC(MYLAN NV)
KSM 21.06.21

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - HORMONE REPLACEMENT THERAPY
  • TABLE 2: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL ESTROGEN HORMONE REPLACEMENT THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: GLOBAL ESTROGEN HORMONE REPLACEMENT THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL THYROID HORMONE REPLACEMENT THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: GLOBAL THYROID HORMONE REPLACEMENT THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL TESTOSTERONE HORMONE REPLACEMENT THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: GLOBAL TESTOSTERONE HORMONE REPLACEMENT THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL HUMAN GROWTH HORMONE REPLACEMENT THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: GLOBAL HUMAN GROWTH HORMONE REPLACEMENT THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL PROGESTOGEN HORMONE REPLACEMENT THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: GLOBAL PROGESTOGEN HORMONE REPLACEMENT THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL MENOPAUSE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 17: GLOBAL MENOPAUSE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL MALE HYPOGONADISM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 19: GLOBAL MALE HYPOGONADISM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL GROWTH HORMONE DEFICIENCY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 21: GLOBAL GROWTH HORMONE DEFICIENCY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL HYPOTHYROIDISM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 23: GLOBAL HYPOTHYROIDISM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL OTHER INDICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 25: GLOBAL OTHER INDICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 27: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL ORAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 29: GLOBAL ORAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL PARENTERAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 31: GLOBAL PARENTERAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL TRANSDERMAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 33: GLOBAL TRANSDERMAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL OTHER ROUTE OF ADMINISTRATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 35: GLOBAL OTHER ROUTE OF ADMINISTRATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 37: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY REGION, FORECAST YEARS 2021-2028 (IN $ MILLION)
  • TABLE 38: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 39: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 40: LEADING PLAYERS OPERATING IN NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET
  • TABLE 41: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 42: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 43: LEADING PLAYERS OPERATING IN EUROPE HORMONE REPLACEMENT THERAPY MARKET
  • TABLE 44: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 45: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 46: LEADING PLAYERS OPERATING IN ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET
  • TABLE 47: REST OF WORLD HORMONE REPLACEMENT THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 48: REST OF WORLD HORMONE REPLACEMENT THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 49: LEADING PLAYERS OPERATING IN REST OF WORLD HORMONE REPLACEMENT THERAPY MARKET
  • TABLE 50: LIST OF MERGERS & ACQUISITIONS
  • TABLE 51: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 52: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 53: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, IN 2020
  • FIGURE 6: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, IN 2020
  • FIGURE 12: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, IN 2020
  • FIGURE 18: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY OTHER ROUTE OF ADMINISTRATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 22: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 23: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 24: CANADA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 25: EUROPE HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 26: GERMANY HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 27: FRANCE HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 28: UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 29: ITALY HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: RUSSIA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 31: BELGIUM HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 32: POLAND HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 33: REST OF EUROPE HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 34: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 35: CHINA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 36: JAPAN HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 37: INDIA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 38: AUSTRALIA & NEW ZEALAND HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 39: SOUTH KOREA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 40: INDONESIA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 41: THAILAND HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 42: VIETNAM HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 43: REST OF ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 44: REST OF WORLD HORMONE REPLACEMENT THERAPY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 45: LATIN AMERICA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 46: MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

KEY FINDINGS

The global hormone replacement therapy market is estimated to project a CAGR of 7.67% during the forecast period, 2021-2028. The awareness of post-menopausal issues, product launches by major players, and growing hormonal disorders drive market growth.

MARKET INSIGHTS

HRT (hormone replacement therapy) replaces hormones like thyroid hormone, progestogen hormone, human growth hormone, and estrogen hormone. One of the significant drivers of market growth is the increasing product launches by major players.

Several players are launching new products to reinforce their foothold in the competitive market. Novo Nordisk received the FDA approval for Sogroya (somapacitan-beco) in 2020 for adult growth hormone deficiency. As a result, the company extended its product reach across the US. Mylan launched Estradiol Vaginal Cream USP in 2018 for treating vaginal and vulvar atrophy. This strengthened its women's healthcare portfolio in several hormone replacement therapy-related disorders. Abbott expanded its product portfolio through its launch of Thyronorm 37.5 mcg tablet for hypothyroidism and Estrabet gel in 2019. Such developments are propelling the market growth. However, the treatment costs and adverse reactions related to HRT hamper the market growth.

REGIONAL INSIGHTS

The global hormone replacement therapy market is geographically segmented into North America, Asia-Pacific, Europe, and Rest of World for growth assessment. With increasing awareness among end-users and improving healthcare infrastructure, Asia-Pacific is evaluated to record the highest CAGR.

COMPETITIVE INSIGHTS

The rising market expansion by players is projected to increase the competitive rivalry. Amgen, Bayer AG, Eli Lilly & Company, ANI Pharmaceuticals, Genentech Inc, Abbott Laboratories, etc., are some of the eminent market players.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. PREVAILING AWARENESS ABOUT POST-MENOPAUSAL ISSUES AMONG WOMEN
    • 3.1.2. INCIDENCE OF HORMONAL DISORDERS
    • 3.1.3. PRODUCT LAUNCHES BY MAJOR PLAYERS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. ADVERSE REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY
    • 3.2.2. HIGH COST OF TREATMENT

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRY
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY THERAPY TYPE

  • 5.1. ESTROGEN HORMONE REPLACEMENT THERAPY
  • 5.2. THYROID HORMONE REPLACEMENT THERAPY
  • 5.3. TESTOSTERONE HORMONE REPLACEMENT THERAPY
  • 5.4. HUMAN GROWTH HORMONE REPLACEMENT THERAPY
  • 5.5. PROGESTOGEN HORMONE REPLACEMENT THERAPY

6. MARKET BY INDICATION

  • 6.1. MENOPAUSE
  • 6.2. MALE HYPOGONADISM
  • 6.3. GROWTH HORMONE DEFICIENCY
  • 6.4. HYPOTHYROIDISM
  • 6.5. OTHER INDICATIONS

7. MARKET BY ROUTE OF ADMINISTRATION

  • 7.1. ORAL
  • 7.2. PARENTERAL
  • 7.3. TRANSDERMAL
  • 7.4. OTHER ROUTE OF ADMINISTRATIONS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. MARKET SIZE & ESTIMATES
    • 8.1.2. KEY GROWTH ENABLERS
    • 8.1.3. KEY CHALLENGES
    • 8.1.4. KEY PLAYERS
    • 8.1.5. COUNTRY ANALYSIS
      • 8.1.5.1. UNITED STATES
      • 8.1.5.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. MARKET SIZE & ESTIMATES
    • 8.2.2. KEY GROWTH ENABLERS
    • 8.2.3. KEY CHALLENGES
    • 8.2.4. KEY PLAYERS
    • 8.2.5. COUNTRY ANALYSIS
      • 8.2.5.1. GERMANY
      • 8.2.5.2. FRANCE
      • 8.2.5.3. UNITED KINGDOM
      • 8.2.5.4. ITALY
      • 8.2.5.5. RUSSIA
      • 8.2.5.6. BELGIUM
      • 8.2.5.7. POLAND
      • 8.2.5.8. REST OF EUROPE
  • 8.3. ASIA-PACIFIC
    • 8.3.1. MARKET SIZE & ESTIMATES
    • 8.3.2. KEY GROWTH ENABLERS
    • 8.3.3. KEY CHALLENGES
    • 8.3.4. KEY PLAYERS
    • 8.3.5. COUNTRY ANALYSIS
      • 8.3.5.1. CHINA
      • 8.3.5.2. JAPAN
      • 8.3.5.3. INDIA
      • 8.3.5.4. AUSTRALIA & NEW ZEALAND
      • 8.3.5.5. SOUTH KOREA
      • 8.3.5.6. INDONESIA
      • 8.3.5.7. THAILAND
      • 8.3.5.8. VIETNAM
      • 8.3.5.9. REST OF ASIA-PACIFIC
  • 8.4. REST OF WORLD
    • 8.4.1. MARKET SIZE & ESTIMATES
    • 8.4.2. KEY GROWTH ENABLERS
    • 8.4.3. KEY CHALLENGE
    • 8.4.4. KEY PLAYERS
    • 8.4.5. REGIONAL ANALYSIS
      • 8.4.5.1. LATIN AMERICA
      • 8.4.5.2. MIDDLE EAST & AFRICA

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. MERGERS & ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 9.1.3. PARTNERSHIPS & AGREEMENTS
    • 9.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
  • 9.2. COMPANY PROFILES
    • 9.2.1. ABBOTT LABORATORIES
    • 9.2.2. AMGEN
    • 9.2.3. ANI PHARMACEUTICALS
    • 9.2.4. BAYER AG
    • 9.2.5. ELI LILLY & COMPANY
    • 9.2.6. GENENTECH INC
    • 9.2.7. IPSEN
    • 9.2.8. MERCK KGAA
    • 9.2.9. NOVARTIS AG
    • 9.2.10. NOVEN PHARMACEUTICALS INC
    • 9.2.11. NOVO NORDISK A/S
    • 9.2.12. PFIZER INC
    • 9.2.13. VIATRIS INC (MYLAN NV)
Back to Top
전화 문의
F A Q